Phreesia, Inc.

Equities

PHR

US71944F1066

Software

Real-time Estimate Cboe BZX 11:28:37 2024-04-16 am EDT 5-day change 1st Jan Change
22.74 USD -0.02% Intraday chart for Phreesia, Inc. -4.21% -1.77%

Cet article est réservé aux membres

Déjà membre ?

Log In

Pas encore membre ?

Inscription Gratuite
Phreesia Insider Sold Shares Worth $610,684, According to a Recent SEC Filing MT
Phreesia Names Jack Callahan as Chief Technology Officer MT
Phreesia Appoints Jack Callahan as Chief Technology Officer CI
Phreesia Fiscal Q4 Net Loss Narrows, Revenue Increases; FY 2025 Revenue Outlook Maintained; Shares Rise After Hours MT
Phreesia Guides For FY 2025 Revenue of $424-$434 Million, vs CIQ Analyst Consensus of $428 Million MT
Earnings Flash (PHR) PHREESIA Posts Q4 Revenue $95M, vs. Street Est of $93.5M MT
Phreesia, Inc. Reports Earnings Results for the Fourth Quarter Ended January 31, 2024 CI
Phreesia, Inc. Reports Earnings Results for the Full Year Ended January 31, 2024 CI
Phreesia Insider Sold Shares Worth $1,630,138, According to a Recent SEC Filing MT
Phreesia Insider Sold Shares Worth $1,046,093, According to a Recent SEC Filing MT
Phreesia Insider Sold Shares Worth $796,441, According to a Recent SEC Filing MT
Phreesia Insider Sold Shares Worth $458,552, According to a Recent SEC Filing MT
Phreesia Insider Sold Shares Worth $264,468, According to a Recent SEC Filing MT
Phreesia Shares Jump After Better-Than-Expected Fiscal Q3 Results MT
Sector Update: Health Care Stocks Mixed Premarket Wednesday MT
Phreesia Q3 Loss Narrows, Revenue Increases; Reiterates Fiscal 2024 Revenue Guidance; Shares Rise After-Hours MT
Phreesia Maintains FY 2024 Revenue Guidance of $353-$356 Million, vs CIQ Analyst Consensus of $354 Million; FY 2025 Guided to $424-$434 Million, vs Consensus of $449.5 Million MT
Earnings Flash (PHR) PHREESIA Posts Q3 Revenue $91.6M, vs. Street Est of $89.8M MT
Phreesia, Inc. Provides Earnings Guidance for the Fiscal Year 2024 and Fiscal Year 2025 CI
Phreesia, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023 CI
North American Morning Briefing : China Outlook -2- DJ
Phreesia, Inc. acquired Connect On Call for $13.9 million. CI
Phreesia Says Patient Activation Measure to Be Included in Medicare's Merit-Based Incentive Payment System MT
Phreesia Announces That the Centers for Medicare and Medicaid Services Has Included the Patient Activation Measure Performance Measure (Pam-Pm) in Its Merit-Based Incentive Payment System, as Well as in 15 Specialty-Specific Measure Sets and Five Mips Value Pathways, Subsets of Measures for Specific Conditions CI
Phreesia Insider Sold Shares Worth $110,790, According to a Recent SEC Filing MT
Chart Phreesia, Inc.
More charts
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. The Company also provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
22.75 USD
Average target price
30.12 USD
Spread / Average Target
+32.42%
Consensus
  1. Stock Market
  2. Equities
  3. PHR Stock
  4. News Phreesia, Inc.
  5. Phreesia : Baird Adjusts Phreesia's Price Target to $62 From $60, Keeps Outperform Rating